0001235802-23-000041.txt : 20230418
0001235802-23-000041.hdr.sgml : 20230418
20230418163059
ACCESSION NUMBER: 0001235802-23-000041
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230418
DATE AS OF CHANGE: 20230418
EFFECTIVENESS DATE: 20230418
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc.
CENTRAL INDEX KEY: 0001401040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-479300
FILM NUMBER: 23827209
BUSINESS ADDRESS:
STREET 1: 301 CARLSON PARKWAY
STREET 2: SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
BUSINESS PHONE: (763) 496-5454
MAIL ADDRESS:
STREET 1: 301 CARLSON PARKWAY
STREET 2: SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
FORMER COMPANY:
FORMER CONFORMED NAME: DiaMedica Inc.
DATE OF NAME CHANGE: 20070525
D
1
primary_doc.xml
X0708
D
LIVE
0001401040
DiaMedica Therapeutics Inc.
301 CARLSON PARKWAY
SUITE 210
MINNEAPOLIS
MN
MINNESOTA
55305
(763) 496-5454
CANADA (FEDERAL LEVEL)
DiaMedica Inc.
Corporation
true
Rick
Pauls
301 Carlson Parkway, Suite 210
Minneapolis
MN
MINNESOTA
55305
Executive Officer
Director
Scott
Kellen
301 Carlson Parkway, Suite 210
Minneapolis
MN
MINNESOTA
55305
Executive Officer
Dominic
Cundari
301 Carlson Parkway, Suite 210
Minneapolis
MN
MINNESOTA
55305
Executive Officer
Julie
Daves
301 Carlson Parkway, Suite 210
Minneapolis
MN
MINNESOTA
55305
Executive Officer
Kirsten
Gruis
301 Carlson Parkway, Suite 210
Minneapolis
MN
MINNESOTA
545305
Executive Officer
R.
Michael
Giuffre
301 Carlson Parkway, Suite 210
Minneapolis
MN
MINNESOTA
55305
Director
Tanya
N.
Lewis
301 Carlson Parkway, Suite 210
Minneapolis
MN
MINNESOTA
55305
Director
James
T.
Parsons
301 Carlson Parkway, Suite 210
Minneapolis
MN
MINNESOTA
55305
Director
Richard
D.
Pilnik
301 Carlson Parkway, Suite 210
Minneapolis
MN
MINNESOTA
55305
Director
Charles
P.
Semba
301 Carlson Parkway, Suite 210
Minneapolis
MN
MINNESOTA
55305
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-04-10
false
true
false
0
750000
750000
0
false
1
0
0
0
false
DiaMedica Therapeutics Inc.
/s/ Scott Kellen
Scott Kellen
Chief Financial Officer and Secretary
2023-04-18